{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-130854","form_type":"8-K","ticker":"FENC","cik":"0001211583","company_name":"FENNEC PHARMACEUTICALS INC.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.878731+00:00","generated_at":"2026-05-29T00:05:06.892315+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fennec repays $13M convertible debt; eliminates $1.5M annual interest","bullets":["Repurchased and redeemed $13M of convertible notes on Dec 18, 2024; fully retires First and Third Closing Notes.","Financed entirely from available cash; eliminates ~$1.5M in annual interest expense.","Pro forma debt facility with Petrichor is ~$19.2M, maturity Sept 2027.","Eliminates potential dilution of ~1.6 million shares from repaid notes.","CEO confirms cash sufficient to fund operations into 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-130854","json":"https://secwatch.observer/filing/0001104659-24-130854.json","markdown":"https://secwatch.observer/filing/0001104659-24-130854.md","text":"https://secwatch.observer/filing/0001104659-24-130854.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1211583/000110465924130854/0001104659-24-130854-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1211583/000110465924130854/tm2431725d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:05:06.892315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}